Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
Ruggenenti P, Reinhard L, Ruggiero B, Perna A, Perico L, Peracchi T, Fidone D, Gennarini A, Benigni A, Cortinovis M, Hoxha E, Remuzzi G. Ruggenenti P, et al. Among authors: remuzzi g. Am J Kidney Dis. 2024 May;83(5):588-600.e1. doi: 10.1053/j.ajkd.2023.10.013. Epub 2023 Dec 25. Am J Kidney Dis. 2024. PMID: 38151224
A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome.
Vivarelli M, Colucci M, Algeri M, Zotta F, Emma F, L'Erario I, Busutti M, Rota S, Capelli C, Introna M, Todeschini M, Casiraghi F, Perna A, Peracchi T, De Salvo A, Rubis N, Locatelli F, Remuzzi G, Ruggenenti P. Vivarelli M, et al. Among authors: remuzzi g. JCI Insight. 2023 Sep 22;8(18):e169424. doi: 10.1172/jci.insight.169424. JCI Insight. 2023. PMID: 37561590 Free PMC article. Clinical Trial.
Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
Ruggenenti P, Ruggiero B, Cravedi P, Vivarelli M, Massella L, Marasà M, Chianca A, Rubis N, Ene-Iordache B, Rudnicki M, Pollastro RM, Capasso G, Pisani A, Pennesi M, Emma F, Remuzzi G; Rituximab in Nephrotic Syndrome of Steroid-Dependent or Frequently Relapsing Minimal Change Disease Or Focal Segmental Glomerulosclerosis (NEMO) Study Group. Ruggenenti P, et al. Among authors: remuzzi g. J Am Soc Nephrol. 2014 Apr;25(4):850-63. doi: 10.1681/ASN.2013030251. Epub 2014 Jan 30. J Am Soc Nephrol. 2014. PMID: 24480824 Free PMC article. Clinical Trial.
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification.
Sethi S, Beck LH Jr, Glassock RJ, Haas M, De Vriese AS, Caza TN, Hoxha E, Lambeau G, Tomas NM, Madden B, Debiec H, D'Agati VD, Alexander MP, Amer H, Appel GB, Barbour SJ, Caravaca-Fontan F, Cattran DC, Casal Moura M, D'Avila DO, Eick RG, Garovic VD, Greene EL, Herrera Hernandez LP, Jennette JC, Lieske JC, Markowitz GS, Nath KA, Nasr SH, Nast CC, Pani A, Praga M, Remuzzi G, Rennke HG, Ruggenenti P, Roccatello D, Soler MJ, Specks U, Stahl RAK, Singh RD, Theis JD, Velosa JA, Wetzels JFM, Winearls CG, Yandian F, Zand L, Ronco P, Fervenza FC. Sethi S, et al. Among authors: remuzzi g. Mayo Clin Proc. 2023 Nov;98(11):1671-1684. doi: 10.1016/j.mayocp.2023.08.006. Epub 2023 Oct 5. Mayo Clin Proc. 2023. PMID: 37804268 Free article.
Intensive BP Control in Patients with CKD and Risk for Adverse Outcomes.
Ku E, McCulloch CE, Inker LA, Tighiouart H, Schaefer F, Wühl E, Ruggenenti P, Remuzzi G, Grimes BA, Sarnak MJ. Ku E, et al. Among authors: remuzzi g. J Am Soc Nephrol. 2023 Mar 1;34(3):385-393. doi: 10.1681/ASN.0000000000000072. Epub 2023 Jan 17. J Am Soc Nephrol. 2023. PMID: 36735510 Free PMC article.
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.
van Zuydam NR, Ahlqvist E, Sandholm N, Deshmukh H, Rayner NW, Abdalla M, Ladenvall C, Ziemek D, Fauman E, Robertson NR, McKeigue PM, Valo E, Forsblom C, Harjutsalo V; Finnish Diabetic Nephropathy Study (FinnDiane); Perna A, Rurali E, Marcovecchio ML, Igo RP Jr, Salem RM, Perico N, Lajer M, Käräjämäki A, Imamura M, Kubo M, Takahashi A, Sim X, Liu J, van Dam RM, Jiang G, Tam CHT, Luk AOY, Lee HM, Lim CKP, Szeto CC, So WY, Chan JCN; Hong Kong Diabetes Registry Theme-based Research Scheme Project Group; Ang SF, Dorajoo R, Wang L, Clara TSH, McKnight AJ, Duffy S; Warren 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group; Pezzolesi MG; GENIE (GEnetics of Nephropathy an International Effort) Consortium; Marre M, Gyorgy B, Hadjadj S, Hiraki LT; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group; Ahluwalia TS, Almgren P, Schulz CA, Orho-Melander M, Linneberg A, Christensen C, Witte DR, Grarup N, Brandslund I, Melander O, Paterson AD, Tregouet D, Maxwell AP, Lim SC, Ma RCW, Tai ES, Maeda S, Lyssenko V, Tuomi T, Krolewski AS, Rich SS, Hirschhorn JN, Florez JC, Dunger D, Pedersen O, Hansen T, Rossing P, Rem… See abstract for full author list ➔ van Zuydam NR, et al. Among authors: remuzzi g. Diabetes. 2018 Jul;67(7):1414-1427. doi: 10.2337/db17-0914. Epub 2018 Apr 27. Diabetes. 2018. PMID: 29703844 Free PMC article.
MAFLD and glomerular hyperfiltration in subjects with prediabetes, visceral obesity and "preserved" kidney function: A cross-sectional study.
Parvanova A, Abbate M, Yañez AM, Bennasar-Veny M, López-González ÁA, Ramírez-Manent JI, Iliev IP, Fresneda S, Arias-Fernandez M, Remuzzi G, Ruggenenti P. Parvanova A, et al. Among authors: remuzzi g. Diabetes Res Clin Pract. 2023 Jul;201:110729. doi: 10.1016/j.diabres.2023.110729. Epub 2023 May 23. Diabetes Res Clin Pract. 2023. PMID: 37230296 Free article.
Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
De Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, Remuzzi G, Trischitta V, Ruggenenti P; BENEDICT Study Group. De Cosmo S, et al. Among authors: remuzzi g. Diabetes. 2009 Dec;58(12):2920-9. doi: 10.2337/db09-0407. Epub 2009 Aug 31. Diabetes. 2009. PMID: 19720797 Free PMC article. Clinical Trial.
1,513 results